Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
san diego blog main
8
×
san diego top stories
biotech
national
san francisco blog main
boston blog main
boston top stories
new york blog main
new york top stories
san francisco top stories
startups
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer immunotherapy
genomics
nonalcoholic steatohepatitis
pfizer
president trump
san diego
abbvie
acute myeloid leukemia
amgen
What
biotech
8
×
new
roundup
drug
annual
attention
bio
cancer
control
days
genomics
investment
medicine
news
podcast
precision
san
today
according
ahead
aiming
akcea
alzheimer’s
ambien
ambys
american
asco
assessed
athena
attendees
august
big
building
busy
camp’s
cases
cash
centers
ceo
chicago
Language
unset
Current search:
biotech
×
" san diego blog main "
×
@xconomy.com
3 years ago
Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report
@xconomy.com
4 years ago
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More